Combination of (18)F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma

OBJECTIVE: To identify epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma based on (18)F-fluorodeoxyglucose (FDG) PET/CT radiomics and clinical features and to distinguish EGFR exon 19 deletion (19 del) and exon 21 L858R missense (21 L858R) mutations using FDG PET/CT radiomics....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shen, Li, Yadi, Zhao, Min, Wang, Pengyuan, Xin, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2022
Materias:
Thoracic Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434738/
https://www.ncbi.nlm.nih.gov/pubmed/36047542
http://dx.doi.org/10.3348/kjr.2022.0295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434738/
https://www.ncbi.nlm.nih.gov/pubmed/36047542
http://dx.doi.org/10.3348/kjr.2022.0295

Ejemplares similares